To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

Cirrhosis With Septic Shock Clinical Trial

Official title: A Prospective Study to Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

Status Completed

Clinical Trial Summary

The consecutive patients admitted to Intensive care unit of Hepatology department of ILBS and full filling all the eligibility criteria will be enrolled in 1:1 ration by the process of randomization.- The study is an open level study. The investigators will strictly follow the randomization table to give therapy as per the intervention arm.

• Intervention:-the therapeutic intervention is vasopressor i.e. noradrenaline alone and terlipressin along with noradrenaline to maintain the MAP >65mm Hg.

• Intervention arm

• Arm (A) - Noradrenaline

• Arm (B) - Noradrenaline + low dose terlipressin

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Cirrhosis With Septic Shock
• Fibrosis
• Liver Cirrhosis
• Shock
• Shock, Septic

• NCT number: NCT02468063
• Study type: Interventional
• Source: Institute of Liver and Biliary Sciences, India
• Status: Completed
• Phase: N/A
• Start date: May 1, 2015
• Completion date: May 31, 2017